Showing results (81-90 of 179) with videos related to
Sort By:
Pageof 18
Frontiers in Oncology|October 31, 2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importanceDavid A Schoenfeld, Ross D Merkin, Myrto Moutafi, et al.Journal for Immunotherapy of Cancer|March 27, 2020
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanomaNicholas D Klemen, Melinda Wang, Jill C Rubinstein, et al.Infection Control and Hospital Epidemiology|July 21, 2020
Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemicDan M Kluger, Yariv Aizenbud, Ariel Jaffe, et al.Plos One|February 23, 2012
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cellsChristopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, et al.Biorxiv : the Preprint Server for Biology|December 19, 2025
Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusionsNoam S Gaiger, Jack Coburn, Mark N Lee, et al.Molecular Cancer|December 13, 2022
Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failureRihao Qu, Yuval Kluger, Junchen Yang, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 10, 2004
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer modelHarriet M Kluger, Yuval Kluger, Maureen Gilmore-Hebert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic MelanomaPok Fai Wong, Wei Wei, James W Smithy, et al.Journal of Neuro-Oncology|August 5, 2021
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysisMani Ratnesh S Sandhu, Veronica L Chiang, Thuy Tran, et al.Journal for Immunotherapy of Cancer|March 24, 2017
Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanomaJames W Smithy, Lauren M Moore, Vasiliki Pelekanou, et al.Pageof 18